IN THIS ISSUE

Tom Pope
Health plans find themselves paying for the latest and greatest stent without any control over usage. Even bare-metal stents may be overused.
Peer-Reviewed
Joseph R. Twanmoh, MD, FACEP
Gail P. Cunningham, MD, FACEP
Changing the process and mindset of health care professionals was the key to reducing emergency department overcrowding
Legislation & Regulation
John Carroll
Patient advocacy groups work overtime to kill legislation that businesses felt would have provided less costly coverage for their employees
Medication Management
Martin Sipkoff
Despite the higher costs of SSRIs, compared to older antidepressants, limiting members' access can lead to undertreated depression
Employer Update
Lola Butcher
Imagine an America where few businesses purchase health care for employees. Should that come about, the individual market will have new products ready.
Tomorrow's Medicine
Thomas Morrow, MD
Although Myozyme is approved for the infantile form of Pompe disease, it is logical to extend coverage to patients with the late onset form
News and Commentary